...
首页> 外文期刊>Clinical neurology and neurosurgery >Single brain metastasis: Resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery
【24h】

Single brain metastasis: Resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery

机译:单脑转移:与全脑放射线加放射外科手术相比,全脑放射线切除术和转移部位增强

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The most appropriate treatment for a single brain metastasis is still controversial. This matched-pair analysis compared whole-brain irradiation plus radiosurgery (WBI + RS) to neurosurgical resection followed by whole-brain irradiation and a boost to the metastatic site (NR + WBI + B). Methods: The data of 46 patients treated with WBI + RS were matched 1:1 to 46 patients treated with NR + WBI + B with respect to age, gender, Karnofsky performance score (KPS), tumor type, extracerebral metastases, and interval from first diagnosis of cancer to treatment of the metastasis, RPA class, and GPA score. Both groups were compared for local control of the treated metastasis, intracerebral control, and survival. Results: The 1-year local control rates were 85% after WBI + RS and 78% after NR + WBI + B (p = 0.35). The 1-year intracerebral control rates were 74% and 68% (p = 0.33), respectively. The 1-year survival rates were 64% and 58% (p = 0.70), respectively. A multivariate analysis was not performed for local and intracerebral control, because no factor achieved significance on univariate analyses for these endpoints. Improved survival was associated with KPS > 70 (p = 0.032), absence of extracerebral metastases (p = 0.003), RPA-class 1 (p = 0.014), and GPA score of 3.0-4.0 (p = 0.010). Conclusion: Treatment outcomes were not significantly different after WBI + RS or NR + WBI + B. Because WBI + RS is less invasive, it may be preferable for many patients with a single brain metastasis.
机译:目的:单脑转移的最合适治疗方法仍存在争议。该配对分析将全脑放疗加放射外科手术(WBI + RS)与神经外科切除,全脑放疗和转移部位增强(NR + WBI + B)进行了比较。方法:将46例WBI + RS患者的数据与年龄,性别,卡氏性能评分(KPS),肿瘤类型,脑外转移以及间隔时间的1:1与46例NR + WBI + B患者的数据相匹配。首先诊断癌症,以治疗转移,RPA类和GPA评分。比较两组的治疗转移局部控制,脑内控制和生存率。结果:WBI + RS后1年局部控制率是NR + WBI + B后1年局部控制率是78%(p = 0.35)。 1年脑控制率分别为74%和68%(p = 0.33)。 1年生存率分别为64%和58%(p = 0.70)。对于局部和脑内对照,未进行多变量分析,因为在这些终点的单变量分析中没有任何因素达到显着性。生存改善与KPS> 70(p = 0.032),无脑外转移(p = 0.003),RPA 1级(p = 0.014)和GPA评分3.0-4.0(p = 0.010)有关。结论:WBI + RS或NR + WBI + B后的治疗结果无显着差异。由于WBI + RS的浸润性较小,因此对于许多单脑转移患者而言可能更可取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号